Drug & intervention
iloperidone
RxCUI 73178
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Iloperidone
Iloperidone, sold under the brand name Fanapt among others, is an atypical antipsychotic for the treatment of schizophrenia and bipolar I disorder.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
14 shownEvaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNCT07090161 · 2025-09-15
RECRUITINGRandomized Withdrawal Study in Patients With SchizophreniaNCT06961968 · 2025-05-14
RECRUITINGSafety and Tolerability of Open-Labeled Iloperidone in AdolescentsNCT05648591 · 2023-05-24
RECRUITINGA Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease PsychosisNCT05344365 · 2022-06-01
WITHDRAWNA Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of SchizophreniaNCT04712734 · 2021-01-13
COMPLETEDEvaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or SchizophreniaNCT04127058 · 2019-10-07
COMPLETEDFamily Intervention in Recent Onset Schizophrenia Treatment (FIRST)NCT02600741 · 2015-07-24
COMPLETEDRisperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With SchizophreniaNCT02453893 · 2013-11-01
UNKNOWNEfficacy and Safety Study of Iloperidone Virus Risperidone to Treat SchizophreniaNCT01623713 · 2012-06-01
COMPLETEDIloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityNCT01464229 · 2012-04-01
COMPLETEDAssessing the Effects of Fanapt® on Social Cognition in SchizophreniaNCT01929889 · 2012-04-01
TERMINATEDRelapse Prevention Study in Patients With SchizophreniaNCT01291511 · 2011-02-01
COMPLETEDSwitching to Iloperidone From Other Antipsychotics in SchizophreniaNCT01207414 · 2010-08-01
COMPLETEDEfficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaNCT00254202 · 2005-11-18
COMPLETEDConditions being studied
Research locations
AtlantaGeorgia, United States6AustinTexas, United States4San DiegoCalifornia, United States4St LouisMissouri, United States4Staten IslandNew York, United States4ChicagoIllinois, United States3CincinnatiOhio, United States3Garden GroveCalifornia, United States3HoustonTexas, United States3Oklahoma CityOklahoma, United States3PhiladelphiaPennsylvania, United States3Salt Lake CityUtah, United States3
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.